Fei‐Yu Han
Impact in
- Neurology top 5%
- Neurofibromatosis and Schwannoma Cases
- Amyotrophic Lateral Sclerosis Research
- Neuroblastoma Research and Treatments
- Rheumatology top 10%
- Bone Tumor Diagnosis and Treatments
Papers in
-
- Neurofibromatosis and Schwannoma Cases 4
- Neuroblastoma Research and Treatments 2
-
- Glycosylation and Glycoproteins Research 2
- Co-authors
- Martin Ruttledge (5 shared papers)Jan P. Dumanski (5 shared papers)Ya‐Gang Xie (6 shared papers)Myriam Peyrard (3 shared papers)Ingegerd Fransson (4 shared papers)Ian Dunham (3 shared papers)V. Peter Collins (1 shared paper)Denise A. Figlewicz (1 shared paper)
In The Last Decade
Fei‐Yu Han
11 papers receiving 641 citations
Peers
Comparison fields: 5 of 66
- Neurology 362
- Rheumatology 120
- Epidemiology 241
- Genetics 63
- Cell Biology 73
Countries citing papers authored by Fei‐Yu Han
This map shows the geographic impact of Fei‐Yu Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei‐Yu Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei‐Yu Han more than expected).
Fields of papers citing papers by Fei‐Yu Han
This network shows the impact of papers produced by Fei‐Yu Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei‐Yu Han. The network helps show where Fei‐Yu Han may publish in the future.
Co-authors
The 25 scholars most cited alongside Fei‐Yu Han, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease. | 1996 | 196 |
| 2 | 1994 | 101 | |
| 3 | 1999 | 97 | |
| 4 | 1994 | 81 | |
| 5 | Regulation of cisplatin resistance and homologous recombinational repair by the TFIIH subunit XPD. | 2002 | 72 |
| 6 | 1996 | 55 | |
| 7 | 1993 | 22 | |
| 8 | 1994 | 11 | |
| 9 | 1998 | 7 | |
| 10 | 1994 | 7 | |
| 11 | 1997 | 5 |
About Fei‐Yu Han
Fei‐Yu Han is a scholar working on Neurology, Molecular Biology, Epidemiology, Oncology and Genetics, having authored 11 papers that have together received 654 indexed citations. Recurring topics across this work include Neurofibromatosis and Schwannoma Cases (4 papers), Meningioma and schwannoma management (2 papers), Glycosylation and Glycoproteins Research (2 papers), Genomic variations and chromosomal abnormalities (2 papers), Neuroblastoma Research and Treatments (2 papers), interferon and immune responses (1 paper), Thyroid Disorders and Treatments (1 paper) and Peptidase Inhibition and Analysis (1 paper). The work is most often cited by research in Neurology (362 citations), Rheumatology (120 citations), Epidemiology (241 citations), Genetics (63 citations) and Cell Biology (73 citations). Fei‐Yu Han has collaborated with scholars based in Sweden, Canada and Belgium. Frequent co-authors include Martin Ruttledge, Jan P. Dumanski, Ya‐Gang Xie, Myriam Peyrard, Ingegerd Fransson, Ian Dunham, V. Peter Collins, Denise A. Figlewicz, Magnus Nordenskjöld and Karen Rooke. Their work appears in journals such as Human Molecular Genetics, Genomics, Gene, Neurology and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.